Floatz logo

Therapeutic Asset Ratings

395 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
IODINE-125
Prostate Cancer
University Hospital, GrenobleN/AD (26)
Lutetium-Psma
Prostate Cancer
Medical University of ViennaD (26)
METAMIZOLE
Prostate Cancer
Hospital Universitari Vall d'Hebron Research InstituteN/AD (26)
METARAMINOL
Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di BolognaN/AD (26)
Midodrine
Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di BolognaN/AD (26)
Natalizumab
Prostate Cancer
Institut du Cancer de Montpellier - Val d'AurelleN/AD (26)
NORADRENALINE TARTRATE IMPURITY C
Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di BolognaN/AD (26)
omn54
Prostate Cancer
Omnitura Therapeutics, Inc.D (26)
Plavix
Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di BolognaN/AD (26)
PRAVASTATIN
Prostate Cancer
McMaster UniversityN/AD (26)
R-Tm123
Prostate Cancer
AvenCell Therapeutics, Inc.D (26)
Teriflunomide
Prostate Cancer
Institut du Cancer de Montpellier - Val d'AurelleN/AD (26)
tm123
Prostate Cancer
AvenCell Therapeutics, Inc.D (26)
qlg1080
Prostate Cancer
Qilu Pharmaceutical Co., Ltd.P3NR (0)
Cu-Nu101
Prostate Cancer
Hoag Memorial Hospital PresbyterianP2NR (0)
glr2037
Prostate Cancer
Gan & Lee Pharmaceuticals.P1NR (0)
qlf4113 for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd.P1NR (0)
161tb-lnc1011
Prostate Cancer
Peking Union Medical College HospitalEarly P1NR (0)
177lu-fc516
Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.Early P1NR (0)
[177lu]lu-psma-137
Prostate Cancer
Peking University First HospitalEarly P1NR (0)
Showing 376 to 395 of 395 assets
PreviousPage 16 of 16Next